elranatamab will boost the stage or influence of fentanyl transdermal by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Observe. Elranatamab causes cytokine release syndrome (CRS) that will suppress activity of CYP enzymes, resulting in enhanced publicity of CYP substrates.isavuconazonium sulfate will raise the stage or influenc